BIO GREEN MED SOLUTION - BGMS 6 PERP (BGMSP) Stock Price, Forecast & Analysis
USA - NASDAQ:BGMSP - US23254L2079
BGMSP Key Statistics, Chart & Performance
The current stock price of BGMSP is 5.1 USD. In the past month the price decreased by -8.73%.
BGMSP Latest News, Press Relases and Analysis
BGMSP Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 24.75 | 413.15B | ||
| AMGN | AMGEN INC | 15.73 | 185.19B | ||
| GILD | GILEAD SCIENCES INC | 15.53 | 157.81B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 25.09 | 111.66B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.12 | 76.88B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 906.47 | 60.60B | ||
| INSM | INSMED INC | N/A | 42.62B | ||
| NTRA | NATERA INC | N/A | 29.32B | ||
| BIIB | BIOGEN INC | 10.09 | 24.75B | ||
| UTHR | UNITED THERAPEUTICS CORP | 18.06 | 21.56B | ||
| INCY | INCYTE CORP | 16.18 | 20.29B | ||
| NBIX | NEUROCRINE BIOSCIENCES INC | 33.17 | 13.75B |
Related stock screener links
About BGMSP
Company Profile
Bio Green Med Solution, Inc. is a clinical stage biopharmaceutical company, which engages in the provision of cell cycle, transcriptional regulation and DNA damage response biology to develop medicines for cancer and other proliferative diseases. The company is headquartered in Berkeley Heights, New Jersey. The company develops medicines based on cell cycle, epigenetics and mitosis biology. Its Polo-like kinase 1 (PLK1) is a serine/threonine kinase with a central role in cell division and an important regulator of the DNA damage checkpoint. PLK1 overexpression correlates with poor patient prognosis in several tumors, including esophageal, gastric, leukemia, non-small cell lung cancer, ovarian, and squamous cell cancers, as well as MYC-amplified cancers. Plogosertib is a novel, small molecule, selective and potent PLK1 inhibitor. Its Fire Safety division specializes in supplying and trading various protective and fire safety equipment to both domestic and international markets. The company provides fire safety products, including fire extinguishers, foam systems, fire-resistant doors, personal protective equipment, and fire safety apparel.
Company Info
BIO GREEN MED SOLUTION - BGMS 6 PERP
200 Connell Dr Ste 1500
Berkeley Heights NEW JERSEY US
Employees: 0
Phone: 19085177330
BIO GREEN MED SOLUTION - BGMS 6 PERP / BGMSP FAQ
What does BGMSP do?
Bio Green Med Solution, Inc. is a clinical stage biopharmaceutical company, which engages in the provision of cell cycle, transcriptional regulation and DNA damage response biology to develop medicines for cancer and other proliferative diseases. The company is headquartered in Berkeley Heights, New Jersey. The company develops medicines based on cell cycle, epigenetics and mitosis biology. Its Polo-like kinase 1 (PLK1) is a serine/threonine kinase with a central role in cell division and an important regulator of the DNA damage checkpoint. PLK1 overexpression correlates with poor patient prognosis in several tumors, including esophageal, gastric, leukemia, non-small cell lung cancer, ovarian, and squamous cell cancers, as well as MYC-amplified cancers. Plogosertib is a novel, small molecule, selective and potent PLK1 inhibitor. Its Fire Safety division specializes in supplying and trading various protective and fire safety equipment to both domestic and international markets. The company provides fire safety products, including fire extinguishers, foam systems, fire-resistant doors, personal protective equipment, and fire safety apparel.
What is the current price of BGMSP stock?
The current stock price of BGMSP is 5.1 USD. The price decreased by -1.35% in the last trading session.
Does BGMSP stock pay dividends?
BIO GREEN MED SOLUTION - BGMS 6 PERP (BGMSP) has a dividend yield of 8.7%. The yearly dividend amount is currently 0.03.
How is the ChartMill rating for BIO GREEN MED SOLUTION - BGMS 6 PERP?
BGMSP has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Which stock exchange lists BGMSP stock?
BGMSP stock is listed on the Nasdaq exchange.
Is BIO GREEN MED SOLUTION - BGMS 6 PERP (BGMSP) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on BGMSP.
What is the employee count for BGMSP stock?
BIO GREEN MED SOLUTION - BGMS 6 PERP (BGMSP) currently has 0 employees.
BGMSP Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to BGMSP.
BGMSP Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to BGMSP. BGMSP scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
BGMSP Financial Highlights
Over the last trailing twelve months BGMSP reported a non-GAAP Earnings per Share(EPS) of -80.13. The EPS increased by 96.34% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -85.49% | ||
| ROE | -98.28% | ||
| Debt/Equity | 0 |
BGMSP Forecast & Estimates
For the next year, analysts expect an EPS growth of 39.49% and a revenue growth 88.68% for BGMSP